Literature DB >> 2358858

Plasma carcinoembryonic antigen as an indicator of cerebral metastases.

E A Eden1, J M Muggia, E M Hiesiger, F M Muggia.   

Abstract

Four patients in whom the plasma CEA reflected the clinical course of intracranial disease are presented. We conclude that a search to explain an elevated CEA should include the central nervous system. In addition, in selected patients with brain metastases the plasma CEA is a helpful indicator of tumor control and of its response to radiation and chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358858     DOI: 10.1007/bf00177362

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  9 in total

1.  Letter: Cerebral metastases and carcinoembryonic antigen in CSF.

Authors:  L S Snitzer; E C McKinney; F Tejada; M M Sigel; H L Rosomoff; C G Zubrod
Journal:  N Engl J Med       Date:  1975-11-20       Impact factor: 91.245

Review 2.  Cerebrospinal fluid biochemical markers in central nervous system tumors: a review.

Authors:  W R Wasserstrom; M K Schwartz; M Fleisher; J B Posner
Journal:  Ann Clin Lab Sci       Date:  1981 May-Jun       Impact factor: 1.256

3.  Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.

Authors:  H C Falkson; J J Van Der Watt; M A Portugal; M J Pitout; G Falkson
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

4.  Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.

Authors:  C L Loprinzi; D C Tormey; P Rasmussen; G Falkson; T E Davis; H C Falkson; A Y Chang
Journal:  J Clin Oncol       Date:  1986-01       Impact factor: 44.544

5.  Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis.

Authors:  G G Klee; R D Tallman; J R Goellner; T Yanagihara
Journal:  Mayo Clin Proc       Date:  1986-01       Impact factor: 7.616

6.  The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.

Authors:  D E Haagensen; W F Barry; T A McCook; J Giannola; S Ammirata; S A Wells
Journal:  Ann Surg       Date:  1980-05       Impact factor: 12.969

7.  Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.

Authors:  A W Mughal; G N Hortobagyi; H A Fritsche; A U Buzdar; H Y Yap; G R Blumenschein
Journal:  JAMA       Date:  1983-04-08       Impact factor: 56.272

8.  Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.

Authors:  H C Falkson; J J van der Watt; M A Portugal; H S Schoeman; G Falkson
Journal:  Cancer Treat Rep       Date:  1979-08

9.  Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.

Authors:  J J Lokich; N Zamcheck; M W Lowenstein
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.